TickerFacts.

Zivo Bioscience, Inc. (ZIVO): R&D Expense

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.13M
Year ended 2024-12-31
$3.70M
Trailing 12 months to 2025-09-30
+17.1%
3-year compound annual growth
$3.75M2010-12-31: $395.6K2011-12-31: $377.9K2012-12-31: $677.5K2013-12-31: $1.02M2014-12-31: $1.97M2015-12-31: $1.03M2016-12-31: $789.0K2017-12-31: $2.38M2018-12-31: $2.81M2019-12-31: $2.31M2020-12-31: $3.75M2021-12-31: $1.95M2022-12-31: $2.24M2023-12-31: $1.38M2024-12-31: $3.13M$3.13M
2010-12-31 R&D Expense (USD) 2024-12-31
Period endedR&D ExpenseChange YoYSource filing
2024-12-31$3.13M+127.7%2025-03-18, From 2024-01-01
2023-12-31$1.38M-38.5%2025-03-18, From 2023-01-01
2022-12-31$2.24M+14.9%2024-03-15, From 2022-01-01
2021-12-31$1.95Mn/c2023-03-14, From 2021-01-01
2020-12-31$3.75M+62.8%2022-04-22, From 2020-01-01
2019-12-31$2.31M-18.0%2021-02-25, From 2019-01-01
2018-12-31$2.81M+18.2%2020-03-26, From 2018-01-01
2017-12-31$2.38M+201.8%2019-02-12, From 2017-01-01
2016-12-31$789.0K-23.6%2018-02-21, From 2016-01-01
2015-12-31$1.03M-47.6%2017-03-31, From 2015-01-02
2014-12-31$1.97M+93.6%2016-03-29, From 2014-01-02
2013-12-31$1.02M+50.3%2015-04-06, From 2013-01-02
2012-12-31$677.5K+79.3%2014-03-31, From 2012-01-02
2011-12-31$377.9K-4.5%2013-03-25, From 2011-01-01
2010-12-31$395.6Kn/a2012-03-30, From 2010-01-02